AU3835885A - Controlled release liquid dosage formulations for pharmaceuticals - Google Patents

Controlled release liquid dosage formulations for pharmaceuticals

Info

Publication number
AU3835885A
AU3835885A AU38358/85A AU3835885A AU3835885A AU 3835885 A AU3835885 A AU 3835885A AU 38358/85 A AU38358/85 A AU 38358/85A AU 3835885 A AU3835885 A AU 3835885A AU 3835885 A AU3835885 A AU 3835885A
Authority
AU
Australia
Prior art keywords
pharmaceuticals
controlled release
liquid dosage
dosage formulations
release liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38358/85A
Other languages
English (en)
Inventor
Benton Ben Franklin
Gardner David Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Battelle Development Corp
Original Assignee
Battelle Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Development Corp filed Critical Battelle Development Corp
Publication of AU3835885A publication Critical patent/AU3835885A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU38358/85A 1984-01-13 1985-01-09 Controlled release liquid dosage formulations for pharmaceuticals Abandoned AU3835885A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57046984A 1984-01-13 1984-01-13
US570469 2000-05-12

Publications (1)

Publication Number Publication Date
AU3835885A true AU3835885A (en) 1985-07-30

Family

ID=24279767

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38358/85A Abandoned AU3835885A (en) 1984-01-13 1985-01-09 Controlled release liquid dosage formulations for pharmaceuticals

Country Status (11)

Country Link
EP (1) EP0169236A1 (enrdf_load_stackoverflow)
JP (1) JPS61500910A (enrdf_load_stackoverflow)
AU (1) AU3835885A (enrdf_load_stackoverflow)
CA (1) CA1239347A (enrdf_load_stackoverflow)
ES (1) ES8605975A1 (enrdf_load_stackoverflow)
GR (1) GR850069B (enrdf_load_stackoverflow)
IL (1) IL74049A0 (enrdf_load_stackoverflow)
IT (1) IT1184309B (enrdf_load_stackoverflow)
NZ (1) NZ210785A (enrdf_load_stackoverflow)
WO (1) WO1985003000A1 (enrdf_load_stackoverflow)
ZA (1) ZA85239B (enrdf_load_stackoverflow)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302065B1 (en) * 1986-03-21 1994-08-10 Eurasiam Laboratories, Inc. Pharmaceutical compositions
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
IT1226940B (it) * 1988-09-16 1991-02-22 Recordati Chem Pharm Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
EP0535937B2 (en) * 1991-10-01 2008-05-21 Takeda Chemical Industries, Ltd. Prolonged release microparticle preparation and production of the same
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
IL104093A (en) * 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
AU4198793A (en) † 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
PT1165042E (pt) 1999-04-06 2005-06-30 Ethypharm Sa Suspensao farmaceutica bebivel de ibuprofeno
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
WO2004096175A2 (en) * 2003-04-30 2004-11-11 Ranbaxy Laboratories Limited Taste masked microcapsules and processes for their preparation
CA2959414C (en) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation

Also Published As

Publication number Publication date
IL74049A0 (en) 1985-04-30
ZA85239B (en) 1985-08-28
IT8519086A0 (it) 1985-01-11
EP0169236A1 (en) 1986-01-29
GR850069B (enrdf_load_stackoverflow) 1985-05-03
ES8605975A1 (es) 1986-04-01
CA1239347A (en) 1988-07-19
JPS61500910A (ja) 1986-05-08
ES539500A0 (es) 1986-04-01
IT1184309B (it) 1987-10-28
NZ210785A (en) 1987-11-27
WO1985003000A1 (en) 1985-07-18

Similar Documents

Publication Publication Date Title
AU588202B2 (en) Dosage form for delivering acid sensitive beneficial agent
IL80643A0 (en) Controlled release pharmaceutical compositions
AU590308B2 (en) Rate controlled dispenser for administering beneficial agent
IL76651A (en) Release system for two or more active substances
AU6203386A (en) Controlled release tablet
AU3835885A (en) Controlled release liquid dosage formulations for pharmaceuticals
ZA828797B (en) Pharmaceutical formulation
AU586165B2 (en) Drug release device
AU557693B2 (en) Pharmaceutical sustained release compounds
EP0070525A3 (en) Pharmaceutical preparations for external use
AU7756487A (en) Pharmaceutical formulations
AU6064786A (en) Pharmaceutical dosage unit
AU556373B2 (en) Stable pharmaceutical tablet
ZA853462B (en) Controlled release pharmaceutical preparations
MY8600312A (en) Pharmaceutical formulations
AU2345988A (en) Pharmaceutical composition for piperidinoalkanol-decongestant combination
AU541056B2 (en) Pharmaceuticals formulations
GB2190287B (en) Controlled release ketoprofen pharmaceutical formulation
ZA857643B (en) Release system for two or more active substances
AU584547B2 (en) Pharmaceutical `` -aminoalkyl- `` -alkylphenylacetonitriles
ZA855365B (en) Pharmaceutical formulations for ceftazidime
AU7172381A (en) Medicinal composition
AU543418B2 (en) Pharmaceutical formulation
GB8402574D0 (en) Pharmaceutical formulation
IE850071L (en) Controlled release pharmaceutical formulations